- The Efficacy and Safety of Ezetimibe and Low-Dose Simvastatin as a Primary Treatment for Dyslipidemia in Renal Transplant Recipients
-
Yoon HE, Song JC, Hyoung BJ, Hwang HS, Lee SY, Jeon YJ, Choi BS, Kim YS, Yang CW
- KMID: 1717947
- Korean J Intern Med.
- 2009 Sep;24(3):233-237.
- doi: 10.3904/kjim.2009.24.3.233
BACKGROUND/AIMS: The efficacy and safety of a combination of ezetimibe and low-dose statin as primary treatment for dyslipidemia in renal transplant patients were evaluated prospectively. METHODS: The study enrolled 77... -
- CITED
-
- Close
- SHARE
-
- Close
